After the mutations, it prolongs the activation of NF-κB and promotes chronic inflammation and inflammation-related colorectal cancer, which is also related to the occurrence and development of inflammatory bowel disease [76–78]. The gene discussed is NFKB1; the disease is colorectal cancer.